Generation of safe and therapeutically effective human induced pluripotent stem cell‐derived hepatocyte‐like cells for regenerative medicine
Year: 2017
Type: article
Abstract: Hepatocyte‐like cells (HLCs) differentiated from human induced pluripotent stem (iPS) cells are expected to be applied for regenerative medicine. In this study, we attempted to generate safe and therapeutically effective human iPS‐HLCs for hepatocyte transplantation. First, human iPS‐HLCs were generated from a human leukocyte antigen‐homozygous donor on the assumption that the allogenic transplantation might be carried out. Highly efficient hepatocyte differentiation was performed under a feeder‐free condition using human recombinant laminin 111, laminin 511, and type IV collagen. The percentage of asialoglycoprotein receptor 1‐positive cells was greater than 80%, while the percentage of residual undifferentiated cells was approximately 0.003%. In addition, no teratoma formation was observed even at 16 weeks after human iPS‐HLC transplantation. Furthermore, harmful genetic somatic single‐nucleotide substitutions were not observed during the hepatocyte differentiation process. We also developed a cryopreservation protocol for hepatoblast‐like cells without negatively affecting their hepatocyte differentiation potential by programming the freezing temperature. To evaluate the therapeutic potential of human iPS‐HLCs, these cells (1 × 106 cells/mouse) were intrasplenically transplanted into acute liver injury mice treated with 3 mL/kg CCl4 only once and chronic liver injury mice treated with 0.6 mL/kg CCl4 twice weekly for 8 weeks. By human iPS‐HLC transplantation, the survival rate of the acute liver injury mice was significantly increased and the liver fibrosis level of chronic liver injury mice was significantly decreased. Conclusion: We were able to generate safe and therapeutically effective human iPS‐HLCs for hepatocyte transplantation. (Hepatology Communications 2017;1:1058–1069)
Source: Hepatology Communications
DOI: 10.1002/hep4.1111
Institutions: National Institute of Biomedical Innovation, Health and Nutrition, Japan Science and Technology Agency, The University of Osaka, Institute for Protein Research, The University of Osaka, Kazusa DNA Research Institute, Tokyo Medical and Dental University, Global Center for Medical Engineering and Informatics, The University of Osaka
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: human induced pluripotent stem cells, hepatocyte-like cells, hepatocyte transplantation, hepatocyte differentiation, feeder-free culture, laminin-111, laminin-511, type IV collagen, teratoma formation, cryopreservation, acute liver injury, chronic liver injury, liver fibrosis, regenerative medicine
Open Access status: gold
Estimated APC paid: $2,700
Funders: Pfizer, Naito Foundation
OpenAlex ID: W2763196526
